technetium [99mtc]-h7nd
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 14, 2024 (NCT06443710)
Timeline
Indications
Mechanism of action
- Fibroblast activation protein alphaRadiopharmaceutical
FAP radiopharmaceutical
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07107633 | Phase 2 | Mar 12, 2025 | Pharmadax Inc |
| NCT06443710 | Phase 1 | May 14, 2024 | Pharmadax Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmadax Inc | For profit | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1